The Novotech group in Gallneukirchen in Linz is expanding their own product range. In the past few years REHATRON won over 150 clinics, doctors and therapists as a convinced user in different European countries alpha due to its therapeutic efficiency of, which partly exceptionally successful could treat patients accordingly many thousands. Now pulled the Novotech group the necessary and logical consequence: rather than to accompany this advanced form of therapy only as part of the Division of production and to develop Novotech is committed now to the task, lead REHATRON alpha as producers and rights holders in the future. REHATRON was alpha in recent years on the basis of the findings of significant scientists of the last century such as Tesla, Lahovsky, priors and rife, had recognized that high-frequency energy pulse charges to the human body regenerate cells and cell associations as well as viruses and bacteria can eliminate. A technical implementation of these findings was yet not possible in the past. Only the basic conception and development of REHATRON alpha is made it possible to bring a sophisticated technique, which corresponds to the modern physiological, physical, and medical knowledge, and can be used permanently.
As a medium-sized company, successfully operating since 1990 as a development and service in various fields of technology, we opted early 2011, to include REHATRON alpha as producers and rights holders in our own product range”, explains Helmut Haller, Managing Director of Novotech Electronics GmbH. our decision was lies in the fact that we on the one could take insight into the therapeutic treatment successes our production and development activity during, the US convinced, and on the other hand, that the pioneers of this form of therapy personally had the desire. that we continue to ensure alpha for REHATRON as renowned and agile companies.” Now, this will do the Novotech group. Accordingly a new Web portal will go in a few days online, both for users as well as for interested parties as well as for patients alpha ready keep many more and also detailed information about the non-invasive induction therapy with REHATRON. Learn more about the Novotech group itself are can be found at. Katja C. Schmidt, nexus communications agency